XGene Video
See the system, not just the conclusion.
Visual briefings for CMC, quality, data integrity, inspection, remediation, and regulatory decision-making. Only approved public video sources are presented.
VISUAL EVIDENCE / CMC + GMP
▶EXPLAIN
00:0003:20
01Process signalAssay · trend · batch
02Regulatory contextCMC · GMP · FDA
03Decision viewSee the system
Video library
Use visual explanation when the system is easier to see than describe.
Archived review records remain governed and excluded. New videos appear here only after an approved public source is configured.
Program in preparation
No public XGene videos are released yet.
The video system is ready without publishing archived review records or inventing placeholder media. Use current XGene analysis and regulatory intelligence while approved videos are prepared.
Related analysis
Continue from visual explanation into the underlying evidence.
ArticleThe ICH Q11 Three-Part Justification — What FDA and EMA Require for Starting Material Designation and Where Programs Fall ShortThe starting material designation in a drug substance synthesis is one of the highest-stakes decisions in small molecule CMC development — and…Read analysis →
ArticleFDA Inspection Front Room Protocol — What to Say and What Not ToThe most consequential decisions during an FDA inspection are not made in the laboratory or on the manufacturing floor — they are…Read analysis →
ArticleSalt and Co-Crystal Selection: CMC Documentation of Pharmaceutical Form Decisions in Module 3Salt selection is the first CMC decision that determines whether your drug will be manufacturable, stable, and bioavailable — and it is…Read analysis →